Literature DB >> 7637871

Presence and effects of pituitary adenylate cyclase activating peptide in the submandibular gland of the ferret.

G Tobin1, A Asztély, A V Edwards, J Ekström, R Håkanson, F Sundler.   

Abstract

Pituitary adenylate cyclase activating peptide (PACAP), a recently described vasoactive intestinal peptide-like neuropeptide, was found to be present in neurons in the submandibular gland of the ferret, where PACAP-immunoreactive nerve fibers were distributed around blood vessels, acini and ducts. Most of the PACAP-immunoreactive fibres were distinct from those storing vasoactive intestinal peptide. PACAP occurs in tissues as PACAP1-38 and PACAP1-27. PACAP1-38 and PACAP1-27 but not PACAP16-38 displayed biological activity with about the same potency. They exerted vasodilator effects on the submandibular vasculature, which resulted in a greater fall in vascular resistance than an equimolar dose of vasoactive intestinal peptide. The vasodilator response was independent of muscarinic receptor activation. Neither vasoactive intestinal peptide nor PACAP alone evoked any flow of saliva. However, both vasoactive intestinal peptide and PACAP enhanced the fluid response to acetylcholine, and the flow of saliva as well as the output of protein in response to parasympathetic nerve stimulation, vasoactive intestinal peptide being more potent than PACAP. In vitro, protein was released from submandibular gland tissue in response to both vasoactive intestinal peptide and PACAP, vasoactive intestinal peptide being more potent than PACAP. PACAP (and vasoactive intestinal peptide) exerted its in vitro effect following adrenoceptor and muscarinic blockade and following degeneration of sympathetic nerves. Sympathetic denervation combined with parasympathetic preganglionic denervation resulted in supersensitivity to both vasoactive intestinal peptide and PACAP. The fact that PACAP and vasoactive intestinal peptide occur in different nerve fibre populations suggests different roles for the two peptides in the submandibular gland.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637871     DOI: 10.1016/0306-4522(94)00622-c

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  PACAP has anti-apoptotic effect in the salivary gland of an invertebrate species, Helix pomatia.

Authors:  Zsolt Pirger; Jozsef Nemeth; Laszlo Hiripi; Gabor Toth; Peter Kiss; Andrea Lubics; Andrea Tamas; Laszlo Hernadi; Tibor Kiss; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2008-05-13       Impact factor: 3.444

Review 2.  Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation.

Authors:  H Mulder; H Jongsma; Y Zhang; S Gebre-Medhin; F Sundler; N Danielsen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

3.  Identification of endogenous sympathetic neuron pituitary adenylate cyclase-activating polypeptide (PACAP): depolarization regulates production and secretion through induction of multiple propeptide transcripts.

Authors:  C A Brandenburg; V May; K M Braas
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

4.  Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.

Authors:  K M Braas; V May; S A Harakall; J C Hardwick; R L Parsons
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

5.  Investigation of the effects of PACAP on the composition of tear and endolymph proteins.

Authors:  Valeria Gaal; Laszlo Mark; Peter Kiss; Ildiko Kustos; Andrea Tamas; Bela Kocsis; Andrea Lubics; Viktoria Nemeth; Adrienn Nemeth; Laszlo Lujber; Jozsef Pytel; Gabor Toth; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2008-04-18       Impact factor: 3.444

Review 6.  Protective Effects of PACAP in Peripheral Organs.

Authors:  Denes Toth; Edina Szabo; Andrea Tamas; Tamas Juhasz; Gabriella Horvath; Eszter Fabian; Balazs Opper; Dora Szabo; Grazia Maugeri; Agata G D'Amico; Velia D'Agata; Viktoria Vicena; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

7.  PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.

Authors:  Sandor Ferencz; Dora Reglodi; Balint Kaszas; Attila Bardosi; Denes Toth; Zsofia Vekony; Viktoria Vicena; Oszkar Karadi; Dezso Kelemen
Journal:  Oncol Lett       Date:  2019-10-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.